CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells

Journal of Clinical Investigation

Volumn 117, Issue 5, 2007, Pages 1412-1421

  Si, Jutong ^a   Mueller, LeMoyne ^a   Collins, Steven J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE 2 GAMMA; IONOMYCIN; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN KINASE (CALCIUM,CALMODULIN) II; RETINOIC ACID RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME BINDING; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; MYELOID LEUKEMIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; PROMOTER REGIONS (GENETICS); RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; TRETINOIN;

EID: 34248183417     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30779     Document Type: Article

References (47)

1. Gratas, C., Menot, M.L., Dresch, C., and Chomienne, C. 1993. Retinoid acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. Leukemia. 7:1156-1162.
2. Labrecque, J., et al. 1998. Impaired granulocytic differentiation in vitro in hematopoietic cells lacking retinoic acid receptors alpha1 and gamma. Blood. 92:607-615.
3. He, L.-Z., et al. 1998. Distinct interactions of PML-RARα and PLZF- RARα with co-repressors determine differential responses to RA in APL. Nat. Genet. 18:126-135.
4. Lin, R., et al. 1998. Role of the histone deacetylase complex in acute promyelocytic leukemia. Nature. 391:811-814.
5. Huang, M., et al. 1988. Use of all trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72:567-574.
6. Tallman, M.S., Nabhan, C., Feusner, J.H., and Rowe, J.M. 2002. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood. 99:759-767.
7. Heery, D.M., Kalkhoven, E., Hoare, S., and Parker, M.G. 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:733-736.
8. Glass, C.K., and Rosenfeld, M.G. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:121-141.
9. Torchia, J., Glass, C., and Rosenfeld, G. 1998. Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol. 10:373-383.
10. Lee, S.K., et al. 2001. Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2. Mol. Endocrinol. 15:241-254.
11. Rachez, C., et al. 2000. The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol. Cell. Biol. 20:2718-2726.
12. Ren, Y., et al. 2000. Specific structural motifs determine TRAP220 interactions with nuclear hormone receptors. Mol. Cell. Biol. 20:5433-5446.
13. Rochette-Egly, C., et al. 1995. Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. Mol. Endocrinol. 9:860-871.
14. Rochette-Egly, C., Adam, S., Rossignol, M., Egly, J.M., and Chambon, P. 1997. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell. 90:97-107.
15. Keriel, A., Stary, A., Sarasin, A., Rochette-Egly, C., and Egly, J.M. 2002. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha. Cell. 109:125-135.
16. Hook, S.S., and Means, A.R. 2001. Ca(2+)/CaM-dependent kinases: from activation to function. Annu. Rev. Pharmacol. Toxicol. 41:471-505.
17. Anderson, K.A., and Means, A.R. 2002. Defective signaling in a subpopulation of CD4(+) T cells in the absence of Ca(2+)/calmodulin-dependent protein kinase IV. Mol. Cell. Biol. 22:23-29.
18. Nghiem, P., Ollick, T., Gardner, P., and Schulman, H. 1994. Interleukin-2 transcriptional block by multifunctional Ca2+/calmodulin kinase. Nature. 371:347-350.
19. Gaudilliere, B., Konishi, Y., de la Iglesia, N., Yao, G., and Bonni, A. 2004. A CaMKII-NeuroD signaling pathway specifies dendritic morphogenesis. Neuron. 41:229-241.
20. Lisman, J., Schulman, H., and Cline, H. 2002. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat. Rev. Neurosci. 3:175-190.
21. Breitman, T., Selonick, S., and Collins, S. 1980. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. U. S. A. 77:2936-2940.
22. Lanotte, M., et al. 1991. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood. 77:1080-1086.
23. Tsai, S., and Collins, S. 1993. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc. Natl. Acad. Sci. U. S. A. 90:7153-7157.
24. Tokumitsu, H., et al. 1990. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N- methyl-L-tyrosyl]-4-phenylpiperazine, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 265:4315-4320.
25. Sumi, M., et al. 1991. The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem. Biophys. Res. Commun. 181:968-975.
26. Tsai, S., Bartelmez, S., Sitnicka, E., and Collins, S. 1994. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant negative retinoic acid receptor can recapitulate lymphoid, myeloid and erythroid development. Genes Dev. 8:2831-2842.
27. Planas-Silva, M.D., and Means, A.R. 1992. Expression of a constitutive form of calcium/calmodulin dependent protein kinase II leads to arrest of the cell cycle in G2. EMBO J. 11:507-517.
28. Kishimoto, T.K., Jutila, M.A., Berg, E.L., and Butcher, E.C. 1989. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science. 245:1238-1241.
29. Chang, B.H., Mukherji, S., and Soderling, T.R. 2001. Calcium/calmodulin- dependent protein kinase II inhibitor protein: localization of isoforms in rat brain. Neuroscience. 102:767-777.
30. White, R.R., Kwon, Y.G., Taing, M., Lawrence, D.S., and Edelman, A.M. 1998. Definition of optimal substrate recognition motifs of Ca2+-calmodulin- dependent protein kinases IV and II reveals shared and distinctive features. J. Biol. Chem. 273:3166-3172.
31. Stokoe, D., Caudwell, B., Cohen, P.T., and Cohen, P. 1993. The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2. Biochem. J. 296:843-849.
32. Robertson, K., Emami, B., and Collins, S. 1992. Retinoic acid-resistant HL-60R cells harbor a point mutation in the RA receptor ligand binding domain that confers dominant negative activity. Blood. 80:1885-1889.
33. Kao, H.Y., Han, C.C., Komar, A.A., and Evans, R.M. 2003. Co-repressor release but not ligand binding is a prerequisite for transcription activation by human retinoid acid receptor alpha ligand-binding domain. J. Biol. Chem. 278:7366-7373.
34. Kurokawa, R., et al. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature. 377:451-454.
35. Park, D.J., et al. 1999. CCAAT/enhancer binding protein ε is a potential retinoid target gene in acute promyelocytic leukemia treatment. J. Clin. Invest. 103:1399-1408.
36. Collins, S., Robertson, K., and Mueller, L. 1990. Retinoic acid induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha). Mol. Cell. Biol. 10:2154-2163.
37. Fong, Y.L., Taylor, W.L., Means, A.R., and Soderling, T.R. 1989. Studies of the regulatory mechanism of Ca2+/calmodulin-dependent protein kinase II. Mutation of threonine 286 to alanine and aspartate. J. Biol. Chem. 264:16759-16763.
38. Metivier, R., et al. 2003. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell. 115:751-763.
39. Perissi, V., et al. 1999. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13:3198-3208.
40. Nagy, L., et al. 1999. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 13:3209-3216.
41. Means, A.R. 2000. Regulatory cascades involving calmodulin-dependent protein kinases. Mol. Endocrinol. 14:4-13.
42. Si, J., and Collins, S.J. 2002. IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3-dependent manner. Blood. 100:4401-4409.
43. Hanson, P.I., Kapiloff, M.S., Lou, L.L., Rosenfeld, M.G., and Schulman, H. 1989. Expression of a multifunctional Ca2+/calmodulin-dependent protein kinase and mutational analysis of its autoregulation. Neuron. 3:59-70.
44. Hashimoto, Y., and Soderling, T.R. 1987. Calcium • calmodulin-dependent protein kinase II and calcium • phospholipid-dependent protein kinase activities in rat tissues assayed with a synthetic peptide. Arch. Biochem. Biophys. 252:418-425.
45. Johnson, B., et al. 1999. RXR agonist-induced activation of dominant negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation. Mol. Cell. Biol. 19:3372-3382.
46. Butler, A.J., and Parker, M.G. 1995. COUP-TF II homodimers are formed in preference to heterodimers with RXR alpha or TR beta in intact cells. Nucleic Acids Res. 23:4143-4150.
47. Sadowski, I., and Ptashne, M. 1989. A vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res. 17:7539.